Bioequivalence Study of GZR18 Injection Before and After CMC Change

NCT07355738 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

138

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity&T2D

Interventions

DRUG: GZR18 injection A
DRUG: GZR18 injection B

Sponsor

Gan & Lee Pharmaceuticals.